Oxylipins were studied in association with metabolic syndrome in human patients but the specific involvement of Cytochrome P450–soluble epoxide hydrolase (CYP-sEH) pathway remains controversial due to study designs restricted to systemic associations and/or usage of inadequate animal models. The gene discussed is EPHX2; the disease is metabolic syndrome.